ATE91891T1 - Pharmazeutische zusammensetzung fuer die behandlung der kokainsucht. - Google Patents

Pharmazeutische zusammensetzung fuer die behandlung der kokainsucht.

Info

Publication number
ATE91891T1
ATE91891T1 AT88909422T AT88909422T ATE91891T1 AT E91891 T1 ATE91891 T1 AT E91891T1 AT 88909422 T AT88909422 T AT 88909422T AT 88909422 T AT88909422 T AT 88909422T AT E91891 T1 ATE91891 T1 AT E91891T1
Authority
AT
Austria
Prior art keywords
precursor
cocaine addiction
treatment
pharmaceutical composition
phenylalanine
Prior art date
Application number
AT88909422T
Other languages
English (en)
Inventor
Kenneth Blum
Michael C Trachtenberg
Original Assignee
Matrix Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Technologies Inc filed Critical Matrix Technologies Inc
Application granted granted Critical
Publication of ATE91891T1 publication Critical patent/ATE91891T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT88909422T 1987-10-07 1988-09-28 Pharmazeutische zusammensetzung fuer die behandlung der kokainsucht. ATE91891T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10535387A 1987-10-07 1987-10-07
EP88909422A EP0381696B1 (de) 1987-10-07 1988-09-28 Pharmazeutische zusammensetzung für die behandlung der kokainsucht
PCT/US1988/003295 WO1989003211A1 (en) 1987-10-07 1988-09-28 Treatment of cocaine addiction

Publications (1)

Publication Number Publication Date
ATE91891T1 true ATE91891T1 (de) 1993-08-15

Family

ID=22305337

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88909422T ATE91891T1 (de) 1987-10-07 1988-09-28 Pharmazeutische zusammensetzung fuer die behandlung der kokainsucht.

Country Status (5)

Country Link
EP (1) EP0381696B1 (de)
JP (1) JPH03500411A (de)
AT (1) ATE91891T1 (de)
DE (1) DE3882712D1 (de)
WO (1) WO1989003211A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0415693A1 (de) * 1989-08-28 1991-03-06 Arizona Technology Development Corporation Zusammensetzung und Verfahren zur selektiven Verstärkung der Opiat-Wirkung und Verminderung von Opiat-Toleranz und Abhängigkeit
US6541520B1 (en) * 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
US6057368A (en) 1998-08-05 2000-05-02 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
US6890951B2 (en) 1998-08-05 2005-05-10 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
GB9904252D0 (en) * 1999-02-24 1999-04-21 Worsley Andrew P Composition for the treatment of pain
US6395783B1 (en) 2000-10-23 2002-05-28 Brookhaven Science Associates, Llc Treatment of PCP addiction and PCP addiction-related behavior
JP5030194B2 (ja) 2004-11-25 2012-09-19 国立大学法人九州大学 薬物依存症治療剤
GB0501655D0 (en) * 2005-01-26 2005-03-02 Veritron Ltd Therapeutic use
MX357542B (es) 2007-08-06 2018-07-13 Biotie Therapies Inc Nepicastat para usarse en el tratamiento de dependencia.
CA3185236A1 (en) * 2020-07-09 2022-01-13 Ido LIVNEH Tyrosine, tryptophan and phenylalanine as mtor agonists mediating proteasome dynamics, compositions, methods and uses thereof in therapy, and prognostic methods for drug-resistance
CN115317478B (zh) * 2022-08-26 2023-05-02 宁波大学 沙库巴曲缬沙坦类物质在制备药物成瘾和复吸药物的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4312857A (en) * 1977-06-16 1982-01-26 The United States Of America As Represented By The Veterans Administration Novel derivatives of beta-endorphin, intermediates therefor and compositions and methods employing said derivatives
US4439452A (en) * 1979-02-14 1984-03-27 Seymour Enrenpreis Class of analgesics and/or anti-inflammatory agents consisting of inhibitors of breakdown of endogenous enkephalin and/or endorphin, and combinations of said analgesics with antipyretic, anti-inflammatory (aspirin-type) drugs
US4432975A (en) * 1981-04-13 1984-02-21 Icn Pharmaceuticals, Inc. Process for introducing vitamin B-12 into the bloodstream
US4357343A (en) * 1981-06-26 1982-11-02 Baxter Travenol Laboratories, Inc. Nutritional composition for management of renal failure

Also Published As

Publication number Publication date
DE3882712D1 (de) 1993-09-02
EP0381696B1 (de) 1993-07-28
EP0381696A4 (en) 1990-10-10
EP0381696A1 (de) 1990-08-16
JPH03500411A (ja) 1991-01-31
WO1989003211A1 (en) 1989-04-20

Similar Documents

Publication Publication Date Title
SE9500422D0 (sv) New oral pharmaceutical dosage forms
FI973163A0 (fi) Pidätyskyvyttömyyden hoitaminen käyttämällä (S)-oksibutyniiniä ja (S)-desetyylioksibutyniiniä
HUP0100043A2 (hu) Savérzékeny hatóanyagot tartalmazó új gyógyszerforma
ATE211385T1 (de) Anwendungsformen zur behandlung der männlichen erektilen dysfunktion
ATE91891T1 (de) Pharmazeutische zusammensetzung fuer die behandlung der kokainsucht.
HUP0103883A2 (hu) Új, késleltetett felszabadulású, orális készítmények
ATE237330T1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
ES2164040T1 (es) Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
NZ509028A (en) Stable extended release oral dosage composition comprising a pseudoephedrine-containing core, the core being uniformly covered with a desloratadine-containing film
DE502004010303D1 (de) Transdermale arzneimittelzubereitungen mit wirkstoffkombinationen zur behandlung der parkinson-krankheit
HUP0004300A2 (hu) (S)-N-Etil-3-[1-(dimetil-amino)-etil]-N-metil-fenil-karbamátot és antioxidánst tartalmazó gyógyszerkészítmény
HRP20080117A2 (en) Pharmaceutical composition for modified release insulin sensitiser
EA200001201A3 (ru) Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путем
ES2173858T3 (es) Analogos de huperzina a.
DK0904067T3 (da) Transdermalt indgivet dextromethorpan som hostestillende middel
ES2058596T3 (es) Empleo de derivados de l-carnitina en el tratamiento terapeutico de alteraciones degenerativas del sistema nervioso.
HUP0004780A2 (hu) Prosztaglandin agonisták felhasználása merevedési rendellenességek vagy impotencia kezelésében
ATE235901T1 (de) Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma- butyrobetain für die behandlung von herz-gefäss- erkrankungen
DE69808440T2 (de) Verwendung von (+)mefloquine zur behandlung von malaria
DK0701449T3 (da) Fremgangsmåde til fremstilling af en oral fast dosisform indeholdende diclofenac
DE60320039D1 (de) Tramadol-formulierungen mit verzögerter freisetzung und 24-stunden-wirksamkeit
ES2176702T3 (es) Antimicoticos con alta liberacion de sustancia activa.
HUP0000882A2 (hu) NMDA (N-metil-D-aszpartát) antagonista hatású indolszármazékok, valamint a vegyületeket tartalmazó gyógyszerkészítmények
DK0627916T3 (da) Farmaceutisk præparat, anvendeligt som analgetikum og indeholdende (R)-2-(3-benzoylphenyl)propionsyre
ATE334982T1 (de) 7-chlor-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-